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Probiotics and Cardiovascular Disease 
Abstract 
Cardiovascular disease is the leading cause of mortality worldwide, regardless of gender. 
Prevention is key in decreasing morbidity and mortality. Because of this, prevention is geared 
toward decreasing the risk factors of cardiovascular disease. Some risk factors cannot be avoided 
such as family history, genetics, or gender but there are many risk factors that can be avoided or 
modified. These risk factors include hypertension, hyperlipidemia, obesity, tobacco use, 
sedentary lifestyle, and an unhealthy diet. The case report presented is a post-menopausal female 
with hypertension. Other than hypertension she has several other risk factors for cardiovascular 
disease such as a positive family history, unhealthy diet, and borderline high cholesterol. 
Treatment and prevention of her cardiovascular risk factors include controlling her blood 
pressure and cholesterol. Interventions include lifestyle changes, such as dietary modifications 
and exercise, and blood pressure medication. Probiotics are discussed in this report as part of diet 
modification for the female patient. New research has been found linking probiotics to their 
ability in regulating blood pressure, cholesterol, and a healthy weight through the modulation of 
the gut microbiota. Studies have shown the therapeutic and cost-effective potential of the use of 
probiotics in managing cholesterol and hypertension in the future. Further studies are warranted 
to determine what probiotic strains and the amount needed to be ingested to gain the greatest 
cardiovascular benefit.  
Background 
Cardiovascular disease is the number one cause of the death worldwide for both men and 
women (World Health Organization, 2016). Cardiovascular disease encompasses diseases that 




coronary artery disease, cerebral vascular disease, and peripheral arterial disease. Cardiovascular 
disease can significantly be prevented with interventions to target the risk factors of 
cardiovascular disease (World Health Organization, 2016). Some risk factors for cardiovascular 
disease are not modifiable, such as male gender, advancing age, family history of cardiovascular 
disease, and being African American. Modifiable risk factors include hypertension, tobacco use, 
sedentary lifestyle, and hyperlipidemia. Other factors that contribute to cardiovascular disease 
are obesity, stress, and Diabetes mellitus (Dunphy et al., 2015). The modifiable risk factors are 
what is targeted by therapeutic measures. Regular physicals are necessary to identify 
cardiovascular risk factors or problems such as with monitoring blood pressure and cholesterol 
so that lifestyle changes and medications can be started to protect cardiovascular health (Direnzo, 
2013). 
The increased prevalence of cardiovascular diseases is mostly due to the inadequate and 
unsuccessful use of preventative interventions. Therefore, there is a dire need to continue 
developing innovative strategies to both prevent and treat cardiovascular disease. Proper diet and 
nutrition are crucial in decreasing the risk of cardiovascular disease and to protect and enhance 
cardiovascular function in those already with cardiovascular disease. New research is showing 
that probiotics may have the ability to reduce both cholesterol and hypertension, two major risk 
factors of cardiovascular disease, through the modulation of the gut flora or microbiota. An 
impaired balance of the gut microbiota has also been linked to obesity another risk factor for 
cardiovascular disease. This suggests that rebalancing the gut microbiota makeup with the use of 
probiotics may contribute to the ability to maintain a healthy weight and metabolism (Yadav & 




through many different avenues especially when used in conjunction with other lifestyle and diet 
modifications.  
Case Report 
Kathy is a 67-year-old female that presents to the clinic for a follow up on her 
hypertension. Three weeks ago, she started on Lisinopril 20 mg daily. Her blood pressures at 
home has been running in the 150s to 160s systolic and the 70s to 80s diastolic. However, since 
starting on the Lisinopril she has developed a dry cough that she describes as annoying. It wakes 
her up at night. It occurs off and on throughout the day. She denies any shortness of breath, 
dizziness, or chest pain. She also denies any recent upper respiratory infection, nasal congestion, 
or nasal drainage. Her cholesterol was checked six months ago which was borderline. The only 
other medication she is taking is a Multivitamin daily. She has no known drug allergies. She has 
no history of cardiac issues including stroke, heart attack, or chest pain. She does not use 
tobacco. Her mother and father are no longer living. Her mother and father both had a long 
history of hypertension. Her mother had an abdominal aortic aneurism. Her dad had a coronary 
bypass and Squamous Cell Carcinoma. She has two children who are both healthy.  
The physical exam revealed S1 and S2 at a regular rate and rhythm. No murmurs noted. 
PMI nondisplaced. Lung sounds clear bilaterally to posterior and anterior lung fields. Dry 
intermittent cough noted. No signs of respiratory distress. Bilateral tympanic membranes pearly 
gray. Cone of light present to bilateral tympanic membranes. Posterior oropharynx pink and 
moist. Tonsils +1 bilaterally. The nasopharynx is pink and non-edematous. A complete 
metabolic panel was done three weeks ago which was in normal range. Lipid panel checked six 
months ago which was borderline high. Her vital signs today were blood pressure 160/98, pulse 




Assessment is an ACE Inhibitor induced cough. Plan is to discontinue the Lisinopril 
today and to start Losartan 50 mg orally daily. She will return in three weeks to recheck her 
blood pressure and have a complete metabolic panel drawn. Explained to patient the complete 
metabolic panel will be done to assess how the kidneys are handling the new medication. She 
should continue to check her blood pressure daily and write it down. Discussed that the Losartan 
may need to be either increased or another medication added to her regimen since her blood 
pressure is still high with the Lisinopril. A lipid panel will also be rechecked in about six months. 
Discussed with patient that she may be able to decrease her cholesterol with lifestyle changes 
alone. She has started doing water aerobics three times a week which she enjoys. Encouraged to 
continue exercising several times a week. She also has started to eat healthier but asks for 
education regarding a healthy diet. Discussed the DASH diet and gave her written information. 
Discussed the use of probiotics as part of the DASH diet, as new evidence has showed the 
potential of probiotics to decrease cholesterol, blood pressure, and promote a healthy weight. She 
states she saw what cardiovascular problems did to her parents and she would like to avoid any 
for herself if possible. Discussed that modifying her modifiable risk factors with lifestyle 
changes such as diet and exercise will help to increase her cardiovascular health and decrease her 
risk factors in developing cardiovascular problems in the future.  
Literature Review 
Interventions to decrease cardiovascular disease and improve cardiovascular health are 
primarily done by modifying risk factors. There are non-modifiable risk factors for 
cardiovascular disease such as genetics; but there are many modifiable risk factors that if 
modified can decrease the risk of cardiovascular disease. These modifications include exercise, 




decreasing saturated fat, trans fat, and cholesterol. One of the biggest risk factors for 
cardiovascular disease is having a high low density lipid protein (LDL). Thus, one of the main 
priorities for treatment is decreasing the LDL (DiRienzo, 2013).  
Coronary artery disease is the leading cause of death and high cholesterol contributes 
directly (Tomaro-Duchesneau et al., 2014). Elevated LDL in the blood is a precursor to high 
blood pressure and triggers the formation of an atherosclerotic plaque in the arteries (DiRienzo, 
2013). Because of this it is necessary to continue studying different options in preventing and 
treating high cholesterol (Tomaro-Duchesneau et al., 2014). High triglycerides and low high-
density lipid proteins (HDL) are also risk factors but are treated secondarily. Statins are the first-
line medication for treating elevated LDL but should come after dietary and lifestyle 
modifications are ineffective (DiRienzo, 2013). 
 Likewise, dietary and lifestyle modifications should continue with the use of statins or 
other medications that lower cholesterol or blood pressure. Non-pharmacologic therapies need to 
be investigated because some people do not tolerate statins or they are not at high enough risk to 
need a statin. Non-pharmacologic therapy may not always decrease cholesterol as well as a statin 
but will still lower cholesterol without the side effects. Also, combining dietary modifications 
with medications may show the best results. In fact, dietary modifications with the use of 
probiotics may show similar results in decreasing LDL compared to a diet alone low in saturated 
fat and cholesterol (DiRienzo, 2013).  
Probiotics are mostly recognized for their use in preventing diarrhea caused by the use of 
antibiotics. However, their ability to positively impact cardiovascular health by decreasing 
cholesterol and hypertension is not as well-known (Tomaro-Duchesneu et al., 2014). A meta-




normal LDL and results showed that LDL and total cholesterol levels dropped significantly with 
those who ingested the probiotics compared to the control group. It is thought that gram-positive 
bacteria in the gut microbiota influence an increase in the catabolism of cholesterol through an 
enzyme called bile salt hydrolise. Bacteria that produce a high amount of this enzyme are able to 
break down bile salts, which are a precursor to cholesterol, so that they are excreted from the 
body. The body then breaks down cholesterol to replace these broken down bile salts, thus 
lowing serum cholesterol  (Ettinger et al., 2014).  
A review by Tuohy, Fava, and Viola (2014) was done to discuss this recently found 
association between the human gut microbiota and cardiovascular disease, as well as how the gut 
microbiota can be influenced by diet. Fruits, vegetables, and whole grains have long been 
considered part of a heart healthy diet. New research now shows that they increase the diversity 
of gut microbiota, since they include great amounts of fiber, prebiotics, and polyphenols.  These 
findings suggest that it is by modifying the gut microbiota that these foods are retrieving part of 
their cardiovascular benefits. For example, red meat, low fiber, and high fat have long been 
considered the opposite of cardio protective. These foods have now been shown to decrease the 
diversity of the microbiota. These findings suggest that the influence on the gut microbiota may 
have been why these foods were shown to have a positive or negative influence on 
cardiovascular health. 
The gut microbiota has also been shown to change depending on a host’s health status. 
Probiotic bacteria have been found to affect the make-up of the gut microbiota. Because of this it 
is worth studying the cardiovascular benefits in manipulating the gut microbiota with probiotics 
(Ahrén et al., 2014) . Probiotic bacteria in many studies have shown to have “significant 




have many advantages since they are found in many natural foods such as yogurt, cheaper than 
most medications, and safe (Tomaro-Duchesneau et al., 2014). 
According to Mistry (2014) there have been several strains of probiotics that have shown 
to lower LDL cholesterol. These strains include L. reuteri, E. faccium, and L. acidophilus. The 
effect that each one has on reducing cholesterol is variable. A meta-analysis by Zuang et al. 
(2012) showed that probiotics in the diet can decrease total cholesterol by 6.4 mg/dl and LDL by 
4.9 mg/dl. The mechanism is not fully understood. More research is needed because it is not well 
known what probiotic strains and doses are needed to achieve maximum lipid lowering effects. 
Probiotics have been shown to lower cholesterol through several mechanisms. One of the 
mechanisms being cholesterol assimilation (Tomar-Duchesneau et al. (2014). A study by Tomar-
Duchesneau et al. (2014) looked at different Lactobacillus strains and their ability to assimilate 
cholesterol both in a culture media and simulated intestinal conditions. The results showed that 
all the strains had the ability to assimilate cholesterol with Lactobacillus reuteri being the best 
with the ability to assimilate 67% of the cholesterol. A study by Kumar et al. (2013) looked at 
the effect of a probiotic Lactobacillus rhamnosus in combination with Aloe Vera on rats who had 
high cholesterol. The study results show that serum cholesterol and LDL were decreased 
significantly and HDL were increased significantly. Probiotics may be a warranted dietary 
approach in decreasing cholesterol levels among many other health benefits.  
Probiotics may also be able to decrease inflammation throughout the body which adds to 
cardiovascular problems. L reuteri has been shown to decrease inflammatory markers in the 
blood suggesting that probiotics may be able to decrease the risk of cardiovascular disease, type 
2 Diabetes, and obesity. Probiotics, such as L. reuteri, should be considered an addition to a 




(DiRienzo, 2014) (Tomaro-Duchesneau et al., 2014). According to Direnzo (2014) “L. reuteri 
capsules are the only probiotic capsules shown to significantly lower LDL” (p.20) and suggests 
that more studies should be done regarding probiotics used in combination with statins.  
Another risk factor for cardiovascular disease that probiotics may address is 
hypertension. A systematic review by Khalesi et al. (2014) was done to look at probiotics and 
what type of effect they have on blood pressure. Recent human studies have shown that oral 
probiotic intake may have a positive effect on blood pressure control. Probiotics are throught to 
improve blood pressure by decreasing total cholesteral, LDL, insulin resistance and acting on the 
renin-angiotensin system. The systematic review looked at randomized control trials and 
“overall, the results showed that consuming probiotics could significantly reduce systolic bolood 
pressure by 3.56 mmHG and diastolic blood pressue by 2.38 mm HG.” (p.901). Most of the 
studies used fermented milk but there were different types of probiotics used in some studies to 
adequately give conclusions as to what probiotic is best in reducing blood pressure. Fermented 
milk may have properties that act as angiotensin-converting enzyme inhibitors (Khalesi et al., 
2014).  
A study by Ahrén et al. (2014) examined the anti-hypertensive effect of two combined 
probiotics, blueberries and Lactobacillus plantarum, and the association with change in the gut 
microbiota. The study was done in rats and after four weeks the results showed a significant drop 
in blood pressure for the rats that received the probiotic compared to the rats that did not. There 
was also a change in the gut microbiota for the rats that received the probiotic combination. The 
results conclude that the probiotic product had significant anti-hypertensive effects which may 




Probiotics may act in different ways to control blood pressure. They may reduce 
cholesterol with one meta-analysis showing a 6.4 mg/dL decrease in total cholesterol, a 4.9 
mg/dL decres in LDL, and a 3.9 mg/dL decrease in triglycerides. They may regulate the RAS by 
producing properties that act as angiontensin-converting enzyme inhibitors. Reducing weight 
also decreases blood pressure but only one study showed an association in weight loss with 
probiotics. Therefore probiotics may have a few different uses in decreasing the risk of 
cardiovascular disease. The ability probiotics have shown to improve blood pressure control and 
lipids potentiate the future use of probiotics in the treatment and prevention of high blood 
pressure and high cholesterol. Future studies are needed to examine what strains of probiotics 
and what amount is needed to gain maximum benefit (Khalesi et al., 2014). 
Antibiotics increase blood pressure by altering the gut microbiota. Chronic systemic 
inflammation can be due to a decrease in gut microbiota and the inflammation can be due to or a 
result of hypertension (Jose & Raj, 2015). “Preeclampsia is associated with hypertension and 
inflammation, the incidence of which is decreased by chronic intake of probiotics” (p.404). 
Lactobacilli produce peptides that can inhibit angiotensin production and fermented milk when 
ingested has been shown to lower blood pressure in humans who have hypertension. Blueberries 
are also thought to decrease blood pressure by increasing the Lactobacilli in the gut (Jose & Raj, 
2015).   
Lastly, probiotics’ effect on the gut microbiota may positively impact weight regulation. 
Obesity, diabetes, high cholesterol and hypertension are the main medical conditions that 
influence cardiovascular risk (Ebel et al. 2014). “According to the WHO, these diseases are the 
leading cause of worldwide morbidity and mortality” (p.177). New research suggests that the 




microbiota positively impacts “nutrient uptake and energy regulation” (p.178). A recent study on 
obese mice showed that L. rhamnosus given over eight weeks reduced weight without change in 
food intake. “The importance of the microbiota composition in obesity has been shown in model 
laboratory organisms and confirmed in humans” p. (179). The effect of probiotics on decreasing 
hypertension has not been studied as extensively as their effect on cholesterol but there are 
several avenues that warrant investigation further. For example, there have been some bacteria 
found to make nitric oxide which could be used for the vasodilatory effect in decreasing 
hypertension. 
In western civilization heart disease seems to go along with the chronic conditions 
obesity, Type 2 diabetes, and inflammation. Those who are obese have a distinct gut microbiota 
make up different from those who are lean. Overnutrition as well as a diet high in saturated fat, 
cholesteral, and simple sugars changes the gut microbiota make up. Obesity is one of the main 
risk factors for cardiovascular disease due to it being linked to type 2 diabetes, chronic 
inflammation, and hyperlipidemia. A study was done on mice that showed a decrease in weight 
after three weeks of Lactobacillus rhammosus or Lactobacillus sakei daily. There was no change 
in what the mice ate or the amount. The results show that the change in gut microbiota lead to a 
decrease in fat mass. A single probiotic may not get rid of obesity but understanding how the 
microbiota effects “adipose tissue, cholesterol, satiety and other factors associated with 
cardiovascular health, will contribute to identying new probiotic interventions” (Ettinger et al, 
2014, p.722). Probiotics can be used to reestablish a healthy gut microbiotia of that of a lean 





In conclusion, probiotics are very affordable compared to other medications such as ace 
inhibitors, beta blockers, and statins without the side effects. Probiotics could decrease the cost 
of these medications when used in combination. There is still a lot of investigating and 
experimental studies that need to be done on the gut microbiota and the use of the probiotics to 
treat and prevent cardiovascular disease but the potential is there for probiotics to become part of 
therapy in cardiovascular disease (Ettinger et al., 2014). Modifying risk factors for 
cardiovascular disease is the key to promote cardiovascular health and prevent cardiovascular 
disease. Probiotics may have a place in the modification of risk factors for cardiovascular disease 
such as high cholesterol, hypertension, and obesity. Further studies are warrented to determine 
the strains and amount of probiotics necessary to get cardiovascular benefits.  
Learning Points 
• Gut microbiota may be the new target for the prevention, treatment, and management of 
cardiovascular disease 
• Probiotics may be able to lower cholesterol particularly low density lipid protein (LDL), 
decrease hypertension, and help with maintaining a healthy weight by increasing gut 
microbiota diversity 
• Probiotics are inexpensive, have less side effects compared to blood pressure and 
cholesterol medications, and can easily be added to a healthy diet for example a probiotic 
yogurt 
• Lactobacilli are the primary species shown to decrease cholesterol with L. reuteri 
showing the most significant cholesterol lowering capability 
• The risk of cardiovascular disease can be significantly decreased through modifiable risk 
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